Whether you’re exploring new drug candidates or refining a promising one, predictive AI models can do more than just flag potential risks, they can actively inform your design strategy.
By identifying molecular features associated with toxicity, these models give sponsors the opportunity to redesign compounds and reduce adverse effects while preserving therapeutic efficacy.
Trained on more than half a million toxicology studies and over 200 thousand chemical profiles, predictive computational toxicology models can detect risks early in development, helping you make informed decisions with confidence.